Session Type
Meeting
Search Results for Venous Thromboembolism
Abstract Number: J9
SHM Converge 2022
Background: Multiple factors can lead to overuse of diagnostic imaging for venous thromboembolism (VTE). These include fear of missing a potentially fatal diagnosis, low predictive accuracy of clinical gestalt, prediction rules, and risk assessment models for VTE, and increased access to imaging. Diagnostic imaging for deep venous thrombosis (DVT) with doppler ultrasonography, or for pulmonary […]
Abstract Number: O9
SHM Converge 2022
Background: International VTE management guidelines recommend outpatient management for appropriate patients with low-risk deep vein thrombosis (DVT) or pulmonary embolism (PE)[1-3]. Despite the evidence and recommendations, previous studies reported low prevalence of outpatient management, especially for PE[4, 5]. This analysis aimed to characterize trends in outpatient vs. inpatient management of VTE in the last 5 […]
Abstract Number: 104
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: We previously found that red blood cell (RBC) transfusion was a trigger for hospitalization for venous thromboembolism (VTE) in a Medicare population. As peripherally inserted central catheters (PICCs) are both associated with VTE and often used for RBC transfusion, we assessed the prevalence of VTE in patients with PICCs. Methods: We used data from […]
Abstract Number: 116
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Vitamin K antagonists (VKA) remain widely used in the treatment of venous thromboembolism (VTE). During surgical interventions, the prevention of recurrent VTE must be weighed against the increased bleeding risk conferred by anticoagulation. There is a lack of strong evidence to guide the optimal periprocedural management of anticoagulation in patients with prior VTE, and […]
Abstract Number: 118
Hospital Medicine 2020, Virtual Competition
Background: For peripherally compatible infusates planned for
Abstract Number: 118
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Guidelines for peripherally inserted central catheters (PICCs) recommend avoiding insertion if the anticipated use is 5 or fewer days. However, short-term PICC use is common in hospitals. We sought to identify patient-, provider- and device-characteristics associated with short-term PICC use. Methods: Between January 2014 and June 2016, trained abstractors at each of 51 Michigan […]
Abstract Number: 118
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Guidelines recommend pharmacologic venous thromboembolism (VTE) prophylaxis for high risk hospitalized medical patients that do not have an elevated bleeding risk. A systematic review of randomized trials estimates the overall bleeding risk with pharmacologic prophylaxis to be low, at 1/1000 (0.1%). However, it is unclear if the bleeding events were related to pharmacologic prophylaxis […]
Abstract Number: 119
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Guidelines and quality performance measures recommend venous thromboembolism (VTE) prophylaxis in patients hospitalized with stroke if they have paralysis or are confined to bed and also recommend that all hospitalized medical patients have VTE risk assessment performed. The Padua Prediction Score is a validated VTE risk prediction model for medical patients based on clinical […]
Abstract Number: 119
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Prophylactic anticoagulation is effective at reducing the risk of venous thromboembolism (VTE), but can also increase the risk of bleeding. Whether anticoagulant prophylaxis should be modified for underweight patients to minimize bleeding complications is unknown. We sought to determine whether being underweight is associated with the risk of major bleeding in hospitalized medical patients […]
Abstract Number: 129
Hospital Medicine 2020, Virtual Competition
Background: Cancer-associated thrombosis (CAT) is a common complication in patients with malignancy. Management of venous thromboembolism (VTE), in these patients, is challenging due to the high risk of recurrence and inherent risk of bleeding in this population. Direct oral anticoagulants (DOACs) have emerged as a treatment options for CAT. As yet there have not been […]